Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Azenta (Nasdaq: AZTA) announced its participation in the upcoming 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The company's management team will attend the virtual event scheduled for Tuesday, August 12, 2025. This conference provides an opportunity for investors and analysts to engage with Azenta's leadership through one-on-one meetings.
Azenta (Nasdaq: AZTA) ha annunciato la sua partecipazione al prossimo 10° Annuale Needham Virtual MedTech & Diagnostics 1x1 Conference. Il team di gestione dell'azienda parteciperà all'evento virtuale previsto per martedì 12 agosto 2025. Questa conferenza offre un'opportunità a investitori e analisti di interagire con i dirigenti di Azenta tramite incontri individuali.
Azenta (Nasdaq: AZTA) anunció su participación en la próxima 10ª Conferencia Anual Virtual Needham MedTech & Diagnostics 1x1. El equipo directivo de la compañÃa asistirá al evento virtual programado para el martes 12 de agosto de 2025. Esta conferencia brinda una oportunidad para que inversores y analistas se reúnan personalmente con el liderazgo de Azenta.
Azenta (나스ë‹�: AZTA)ëŠ� 다가오는 ì �10íš� ì—°ë¡€ 니드í–� ê°€ìƒ� ë©”ë“œí…Œí¬ ë°� 진단 1대1 컨í¼ëŸ°ìФì—� 참여한다ê³� 발표했습니다. 회사 ê²½ì˜ì§„ì€ 2025ë…� 8ì›� 12ì� 화요ì�ì—� ì˜ˆì •ë� ê°€ìƒ� 행사ì—� ì°¸ì„í•� ì˜ˆì •ìž…ë‹ˆë‹�. ì� 컨í¼ëŸ°ìФëŠ� 투ìžìžì™€ ì• ë„리스트가 Azenta ê²½ì˜ì§„ê³¼ ì¼ëŒ€ì¼ë¡œ 소통í•� ìˆ� 있는 기회ë¥� ì œê³µí•©ë‹ˆë‹�.
Azenta (Nasdaq : AZTA) a annoncé sa participation à la prochaine 10e conférence annuelle virtuelle Needham MedTech & Diagnostics 1x1. L'équipe de direction de l'entreprise assistera à l'événement virtuel prévu pour le mardi 12 août 2025. Cette conférence offre aux investisseurs et analystes une occasion d'échanger en tête-à -tête avec les dirigeants d'Azenta.
Azenta (Nasdaq: AZTA) gab seine Teilnahme an der bevorstehenden 10. jährlichen Needham Virtual MedTech & Diagnostics 1x1 Konferenz bekannt. Das Management-Team des Unternehmens wird an der für Dienstag, den 12. August 2025 geplanten virtuellen Veranstaltung teilnehmen. Diese Konferenz bietet Investoren und Analysten die Möglichkeit, sich in Einzelgesprächen mit der Führung von Azenta auszutauschen.
- None.
- None.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor Relations
[email protected]
Sherry Dinsmore
[email protected]
View original content to download multimedia:
SOURCE Azenta